537: A phase II study of topotecan given as a continuous 21-day infusion every 28 days in platinum pre-treated ovarian carcinoma
- 30 September 1997
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 33, S120
- https://doi.org/10.1016/s0959-8049(97)85053-8
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: